These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Texas
|
93-1216127
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
Large accelerated filer
|
o
|
Accelerated filer
|
o
|
|
Non-accelerated filer
|
o
|
Smaller reporting company
|
x
|
|
(Do not check if a smaller reporting company)
|
|||
|
Class
|
Outstanding at August 14, 2014
|
|
|
Common Stock, par value $.10 per share
|
15,536,275 shares
|
|
Page(s)
|
|||||
|
PART I
|
Financial Information:
|
||||
|
ITEM 1
|
Financial Statements:
|
3 | |||
|
Condensed Balance Sheets (unaudited) —
June 30, 2014 and December 31, 2013
|
3 | ||||
|
Condensed Statements of Operations (Unaudited) - Cumulative Period During the Development Stage (January 1, 1999 to June 30, 2014) and the Six and Three Months Ended June 30, 2014 and 2013
|
4 | ||||
|
Condensed Statements of Cash Flows (Unaudited) - Cumulative Period During the Development Stage (January 1, 1999 to June 30, 2014) and the Six Months Ended June 30, 2014
and 2013
|
5 | ||||
|
Notes to Interim Condensed Financial Statements (Unaudited)
|
6 -12 | ||||
|
ITEM 2
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
13 | |||
|
ITEM 3
|
Quantitative and Qualitative Disclosures About Market Risk
|
14 | |||
|
ITEM 4
|
Controls and Procedures
|
14 | |||
|
PART II
|
Other Information
|
||||
|
ITEM 1.
|
Legal Proceedings.
|
16 | |||
|
ITEM 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds.
|
16 | |||
|
ITEM 3.
|
Defaults upon Senior Securities.
|
16 | |||
|
ITEM 4.
|
Mine Safety Disclosures.
|
16 | |||
|
ITEM 5.
|
Other Information.
|
16 | |||
|
ITEM 6.
|
Exhibits.
|
17 | |||
|
SIGNATURES
|
18 | ||||
|
EXHIBITS
|
|||||
|
June 30,
|
December 31,
|
|||||||
|
2014
|
2013
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash
|
$ | 1,135,752 | $ | 1,221,675 | ||||
|
TOTAL ASSETS
|
$ | 1,135,752 | $ | 1,221,675 | ||||
|
LIABILITIES, PREFERRED STOCK AND STOCKHOLDERS’ EQUITY -
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 12,113 | $ | 14,965 | ||||
|
TOTAL CURRENT LIABILITIES
|
12,113 | 14,965 | ||||||
|
COMMITMENTS AND CONTINGENCIES
|
- | - | ||||||
|
STOCKHOLDERS’ EQUITY:
|
||||||||
|
PREFERRED STOCK,
$1.00 par value; 4,000,000 authorized: Series A 10% Convertible Preferred stock; 50,000 shares authorized; 24,971 shares issued and outstanding as of June 30, 2014 and December 31, 2013: liquidation preference of $2,497,100 as of June 30, 2014 and December 31, 2013
|
2,056,185 | 2,056,185 | ||||||
|
Common stock, $.10 par value 200,000,000 shares authorized; 16,033,862 shares issued and 15,536,275 shares outstanding as of June 30, 2014 and December 31, 2013
|
1,603,387 | 1,603,387 | ||||||
|
Treasury Stock, $.10 par value 497,587 shares as of June 30, 2014 and December 31, 2013
|
(49,759 | ) | (49,759 | ) | ||||
|
Additional paid-in capital
|
2,564,655 | 2,562,577 | ||||||
|
Accumulated deficit
|
(3,626,121 | ) | (3,626,121 | ) | ||||
|
Deficit accumulated during the development stage
|
(1,424,708 | ) | (1,339,559 | ) | ||||
|
TOTAL STOCKHOLDERS’ EQUITY
|
1,123,639 | 1,206,710 | ||||||
|
TOTAL LIABILITIES, PREFERRED STOCK AND STOCKHOLDERS’ EQUITY
|
$ | 1,135,752 | $ | 1,221,675 | ||||
|
For The Six
Months Ended June 30,
|
For The Three
Months Ended June 30,
|
Cumulative During the Development Stage
(January 1, 1999 to
|
||||||||||||||||||
|
2014
|
2013
|
2014
|
2013
|
June 30,
2014)
|
||||||||||||||||
|
NET SALES
|
$ | - | $ | - | $ | - | $ | - | $ | - | ||||||||||
|
EXPENSES:
|
||||||||||||||||||||
|
General and administrative expense
|
85,211 | 52,663 | 51,599 | 30,593 | 960,035 | |||||||||||||||
|
LOSS FROM OPERATIONS
|
(85,211 | ) | (52,663 | ) | (51,599 | ) | (30,593 | ) | (960,035 | ) | ||||||||||
|
OTHER INCOME (EXPENSE)
|
||||||||||||||||||||
|
Interest expense
|
- | - | - | (8,591 | ) | |||||||||||||||
|
Interest and other income
|
62 | 65 | 29 | 33 | 60,246 | |||||||||||||||
|
Change in warrant liability
|
- | - | - | 130,456 | ||||||||||||||||
|
Warrant liability extinguishment from modification of warrants
|
- | - | - | 9,396 | ||||||||||||||||
|
TOTAL OTHER INCOME
|
62 | 65 | 29 | 33 | 191,507 | |||||||||||||||
|
LOSS BEFORE INCOME TAXES
|
(85,149 | ) | (52,598 | ) | (51,570 | ) | (30,560 | ) | (768,528 | ) | ||||||||||
|
Provision for income taxes
|
- | - | - | - | ||||||||||||||||
|
NET LOSS
|
$ | (85,149 | ) | $ | (52,598 | ) | $ | (51,570 | ) | $ | (30,560 | ) | (768,528 | ) | ||||||
|
Accretion of preferred stock to redemption value
|
- | - | - | (656,180 | ) | |||||||||||||||
|
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS
|
$ | (85,149 | ) | $ | (52,598 | ) | $ | (51,570 | ) | $ | (30,560 | ) | $ | (1,424,708 | ) | |||||
|
BASIC AND DILUTED LOSS PER COMMON SHARE
|
$ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | ||||||||
|
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING – BASIC AND DILUTED
|
15,536,275 | 15,536,275 | 15,536,275 | 15,536,275 | ||||||||||||||||
|
For The Six Months
Ended June 30,
|
Cumulative
During the
Development
Stage
(January 1,
1999 to June 30,
|
|||||||||||
|
2014
|
2013
|
2014) | ||||||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||||||
|
Net loss
|
$ | (85,149 | ) | $ | (52,598 | ) | $ | (768,528 | ) | |||
|
Adjustment to reconcile to net loss to net cash used in operating activities:
|
||||||||||||
|
Change in warrant liability
|
- | - | (130,456 | ) | ||||||||
|
Warrant liability extinguishment from modification of warrants
|
(9,396 | ) | ||||||||||
|
Stock based compensation
|
2,078 | 4,405 | 8,668 | |||||||||
|
Change in assets and liabilities:
|
||||||||||||
|
Accounts payable and accrued expenses
|
(2,852 | ) | (2,091 | ) | (3,065 | ) | ||||||
|
Net cash used in operating activities
|
(85,923 | ) | (50,284 | ) | (902,777 | ) | ||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
- | - | - | |||||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||||||
|
Proceeds from convertible debt
|
- | - | 56,500 | |||||||||
|
Proceeds from private placement/exercise of stock warrants
|
- | - | 5,500 | |||||||||
|
Capital contribution
|
- | - | 8,000 | |||||||||
|
Proceeds from private placement
|
- | - | 1,962,358 | |||||||||
|
Cash dividends paid on preferred stock
|
- | - | (5,490 | ) | ||||||||
|
Net cash provided by financing activities
|
- | - | 2,026,868 | |||||||||
|
NET INCREASE (DECREASE) IN CASH
|
(85,923 | ) | (50,284 | ) | 1,124,091 | |||||||
|
Cash, at beginning of period
|
1,221,675 | 1,338,356 | 11,661 | |||||||||
|
CASH, END OF PERIOD
|
$ | 1,135,752 | $ | 1,288,072 | $ | 1,135,752 | ||||||
|
SUPPLEMENTAL CASH FLOW INFORMATION:
|
||||||||||||
|
Cash paid for:
|
||||||||||||
|
Interest
|
$ | - | $ | - | $ | 8,591 | ||||||
|
Income taxes
|
$ | - | $ | - | $ | - | ||||||
|
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:
|
||||||||||||
|
Accretion of preferred stock to redemption value
|
$ | - | $ | - | $ | (656,180 | ) | |||||
|
Modification on warrants to change to equity
|
$ | - | $ | - | $ | 1,176 | ||||||
|
Preferred stock issued as stock dividend
|
$ | - | $ | - | $ | 11,154 | ||||||
|
416 Private Placement Units were issued in exchange for $56,500 of convertible notes plus $5,900 of accrued interest
|
$ | - | $ | - | $ | 62,400 | ||||||
|
68 Private Placement Units were issued in exchange for $8,000 of stock subscriptions plus $2,200 of accrued interest
|
$ | - | $ | - | $ | 10,200 | ||||||
|
Warrant liabilities
|
$ | 141,027 | ||
|
Redeemable and Convertible Preferred Stock
|
1,388,367 | |||
|
Common Stock
|
470,706 | |||
|
Total allocated gross proceeds:
|
$ | 2,000,100 |
|
2014
|
2013
|
|||||||||||||||
|
Number of
warrants
|
Weighted average exercise price
|
Number of
warrants
|
Weighted average exercise price
|
|||||||||||||
|
Balance at January 1
|
6,909,000 | $ | 0.15 | 6,909,000 | $ | 0.15 | ||||||||||
|
Issued during the period
|
- | $ | - | - | $ | - | ||||||||||
|
Exercised during the period
|
- | $ | - | - | $ | - | ||||||||||
|
Expired during the period
|
- | $ | - | - | $ | - | ||||||||||
|
Balance at June 30
|
6,909,000 | $ | 0.15 | 6,909,000 | $ | 0.15 | ||||||||||
|
Fair values
|
June 30,
2014
|
December 31,
2013
|
At transaction
date
|
|||||||||
|
September 7, 2007 financing
|
$ | - | $ | - | $ | 141,027 | ||||||
|
June 30,
2014
|
December 31,
2013
|
At transaction
date
|
||||||||||
|
Warrants outstanding
|
- | - | 6,909,000 | |||||||||
|
Exercise price
|
$ | - | $ | - | $ | 0.15 | ||||||
|
Annual dividend yield
|
- | % | - | % | 4.01 | % | ||||||
|
Expected life (years)
|
- | - | 5 | |||||||||
|
Risk-free interest rate
|
- | % | - | % | 4.14 | % | ||||||
|
Expected volatility
|
- | % | - | % | 53.94 | % | ||||||
|
Six Months ended
June 30, 2014
|
||||
|
Expected term (in years)
|
5 | |||
|
Expected stock price volatility
|
185.25 | % | ||
|
Risk-free interest rate
|
1.48 | % | ||
|
Expected dividend yield
|
- | |||
|
Number of
Options
|
Weighted Average
Exercise Price
|
Weighted Average
Remaining Contractual Life (Years)
|
Aggregate Intrinsic Value
|
|||||||||||||
|
Outstanding at January 1, 2014
|
300,000 | 0.03 | $ | - | $ | 9,000 | ||||||||||
|
Granted
|
5 | |||||||||||||||
|
Exercised
|
- | - | - | - | ||||||||||||
|
Forfeited/expired
|
- | - | - | - | ||||||||||||
|
Outstanding at June 30, 2014
|
300,000 | $ | 0.03 | $ | 5 | $ | 9,000 | |||||||||
|
Exercisable at June 30, 2014
|
300,000 | $ | 0.03 | $ | 5 | $ | 9,000 | |||||||||
|
Carrying
Amount In
Balance Sheet
June 30,
|
Fair Value
June 30,
|
Fair Value Measurement Using
|
||||||||||||||||||
|
2014
|
2014
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||||||
|
Assets:
|
||||||||||||||||||||
|
Money Market Funds
|
$
|
1,135,752
|
$
|
1,135,752
|
$
|
1,135,752
|
$
|
—
|
$
|
—
|
||||||||||
|
Carrying
Amount In
Balance Sheet
December 31,
|
Fair Value
December 31,
|
Fair Value Measurement Using
|
||||||||||||||||||
|
2013
|
2013
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||||||
|
Assets:
|
||||||||||||||||||||
|
Money Market Funds
|
$
|
1,221,675
|
$
|
1,221,675
|
$
|
1,221,675
|
$
|
—
|
$
|
—
|
||||||||||
| Item 4. Controls and Procedures . |
|
Item 1.
|
|
|
None.
|
|
|
Item 2.
|
|
|
None.
|
|
|
Item 3.
|
|
|
None.
|
|
|
Item 4.
|
|
|
Not applicable.
|
|
|
Item 5.
|
|
|
None.
|
|
Number
|
Description
|
|
|
31.1*
|
Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
31.2*
|
Certification of the Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.1*
|
Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.2*
|
Certification of the Principal Financial and Accounting Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
101*
|
Financial Statements from the quarterly report on Form 10-Q of Chase Packaging Corporation for the quarter ended June 30, 2014, filed on August 14, 2014, formatted in XBRL: (i) the Condensed Balance Sheets (Unaudited); (ii) the Condensed Statements of Operations (Unaudited); (iii) the Condensed Statements of Cash Flows (Unaudited); and (iv) the Notes to Interim Condensed Financial Statements (Unaudited) tagged as blocks of text.
|
| CHASE PACKAGING CORPORATION | |||
|
Date: August 14, 2014
|
By: |
/s/ Allen T. McInnes
|
|
|
Allen T. McInnes
|
|||
|
Chairman of the Board, President and Treasurer
|
|||
|
(Principal Executive Officer)
|
|||
|
Date: August 14, 2014
|
By: |
/s/ Ann C. W. Green
|
|
|
Ann C. W. Green
|
|||
|
Chief Financial Officer and Assistant Secretary
|
|||
|
(Principal Financial and Accounting Officer)
|
|||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|